Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,689 | 6,062 | 7,180 | 5,210 | 5,638 |
| TOTAL | $12,965 | $6,462 | $7,986 | $5,590 | $6,172 |
| Non-Current Assets | |||||
| PPE Net | 56 | 58 | 62 | 62 | 30 |
| Intangibles | 254 | 254 | 137 | 137 | 137 |
| Other Non-Current Assets | 689 | 701 | 2,262 | 2,274 | 2,286 |
| TOTAL | $999 | $1,013 | $2,461 | $2,473 | $2,453 |
| Total Assets | $13,964 | $7,475 | $10,446 | $8,063 | $8,626 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 415 | 286 | 185 | 477 | 637 |
| Accrued Expenses | 1,695 | 2,377 | 1,725 | 1,690 | 1,331 |
| Other current liabilities | 10 | 10 | N/A | N/A | N/A |
| TOTAL | $2,171 | $2,722 | $1,958 | $2,213 | $2,042 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,062 | 1,221 | 1,288 | 1,021 | 966 |
| TOTAL | $1,085 | $1,245 | $1,288 | $1,021 | $966 |
| Total Liabilities | $3,256 | $3,967 | $3,246 | $3,234 | $3,008 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38 | 38 | 33 | 32 | 28 |
| Common Shares | 24 | 21 | 20 | 18 | 17 |
| Retained earnings | -53,851 | -50,943 | -45,112 | -40,795 | -36,354 |
| TOTAL | $10,707 | $3,508 | $7,200 | $4,829 | $5,618 |
| Total Liabilities And Equity | $13,964 | $7,475 | $10,446 | $8,063 | $8,626 |